1 |
Chalmers EA. Neonatal coagulation problems. Arch Dis Child Fetal Neonatal Ed 2004;89:F475-8.
DOI
|
2 |
Roberts I, Murray NA. Neonatal thrombocytopenia: causes and management. Arch Dis Child Fetal Neonatal Ed 2003;88:F359-64.
DOI
|
3 |
Saxonhouse MA, Manco-Johnson MJ. The evaluation and management of neonatal coagulation disorders. Semin Perinatol 2009;33: 52-65.
DOI
ScienceOn
|
4 |
Andrew M, Paes B, Johnston M. Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 1990;12:95-104.
DOI
|
5 |
Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, et al. Development of the human coagulation system in the full-term infant. Blood 1987;70:165-72.
|
6 |
Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, et al. Development of the human coagulation system in the healthy premature infant. Blood 1988;72:1651-7.
|
7 |
Reverdiau-Moalic P, Delahousse B, Body G, Bardos P, Leroy J, Gruel Y. Evolution of blood coagulation activators and inhibitors in the healthy human fetus. Blood 1996;88:900-6.
|
8 |
Kenet G, Chan AK, Soucie JM, Kulkarni R. Bleeding disorders in neonates. Haemophilia 2010;16 Suppl 5:168-75.
|
9 |
Mueller-Eckhardt C, Kiefel V, Grubert A, Kroll H, Weisheit M, Schmidt S, et al. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet 1989;1:363-6.
|
10 |
Spencer JA, Burrows RF. Feto-maternal alloimmune thrombocytopenia: a literature review and statistical analysis. Aust N Z J Obstet Gynaecol 2001;41:45-55.
DOI
ScienceOn
|
11 |
Bussel JB, Sola-Visner M. Current approaches to the evaluation and management of the fetus and neonate with immune thrombocytopenia. Semin Perinatol 2009;33:35-42.
DOI
ScienceOn
|
12 |
Kuhle S, Mitchell L, Massicotte P, Andrew M. Hemostatic disorders of the newborn. In: Taeusch HW, Ballard RA, Gleason CA, editors. Avery's diseases of the newborn. 8th ed. Philadelphia: Elsevier Saunders, 2005:1145-79.
|
13 |
Choi JS, Kim SY, Ihm C, Kim SY. A case of neonatal alloimmune thrombocytopenia due to anti-HLA-B35. J Korean Soc Neonatol 2009;16:248-54.
|
14 |
Murphy MF, Bussel JB. Advances in the management of alloimmune thrombocytopenia. Br J Haematol 2007;136:366-78.
DOI
ScienceOn
|
15 |
Bussel J. Diagnosis and management of the fetus and neonate with alloimmune thrombocytopenia. J Thromb Haemost 2009;7 Suppl 1:253-7.
|
16 |
Burrows RF, Kelton JG. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med 1993;329:1463-6.
DOI
ScienceOn
|
17 |
Bussel JB, McFarland JG, Berkowitz RL. Antenatal management of fetal alloimmune and autoimmune thrombocytopenia. Transfus Med Rev 1990;4:149-62.
DOI
ScienceOn
|
18 |
Baehner RL, Strauss HS. Hemophilia in the first year of life. N Engl J Med 1966;275:524-8.
DOI
ScienceOn
|
19 |
Ljung RC. Prenatal diagnosis of haemophilia. Haemophilia 1999;5:84-7.
DOI
ScienceOn
|
20 |
Kulkarni R, Lusher J. Perinatal management of newborns with haemophilia. Br J Haematol 2001;112:264-74.
DOI
ScienceOn
|
21 |
Cox Gill J. Diagnosis and treatment of von Willebrand disease. Hematol Oncol Clin North Am 2004;18:1277-99.
DOI
ScienceOn
|
22 |
Sadler JE. A revised classification of von Willebrand disease. For the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1994;71:520-5.
|
23 |
Gazengel C, Fischer AM, Schlegel N, Rothschild C, Torchet MF, Dautzenberg MD, et al. Treatment of type III von Willebrand's disease with solvent/detergent-treated factor VIII concentrates. Nouv Rev Fr Hematol 1988;30:225-7.
|
24 |
Nichols WC, Ginsburg D. von Willebrand disease. Medicine (Baltimore) 1997;76:1-20.
DOI
ScienceOn
|
25 |
Rha JY, Kook JH, Kook H, Yang SJ, Cho D, Ryang DW, et al. Three cases of factor XI deficiency. Korean J Pediatr Hematol Oncol 2001; 8:344-8.
|
26 |
Kim HJ, Jung JH, Lee JH, Jo JD. A case of congenital factor VII deficiency associated with intraventricular hemorrhage and hydrocephalus. J Korean Pediatr Soc 1998;41:1726-30.
|
27 |
Cho KC, Lee SK, Kim IK, Sung H, Choi CH. A case of combined congenital deficiency of factor V and factor VIII. J Korean Pediatr Soc 1996;39:1162-7.
|
28 |
Townsend CW. The haemorrhagic disease of the newborn. Arch Pediatr 1894;11:559-65.
|
29 |
McNinch A. Vitamin K deficiency bleeding: early history and recent trends in the United Kingdom. Early Hum Dev 2010;86 Suppl 1:63- 5.
|
30 |
Sutor AH, von Kries R, Cornelissen EA, McNinch AW, Andrew M. Vitamin K deficiency bleeding (VKDB) in infancy. ISTH Pediatric/ Perinatal Subcommittee. International Society on Thrombosis and Haemostasis. Thromb Haemost 1999;81:456-61.
|
31 |
Van Winckel M, De Bruyne R, Van De Velde S, Van Biervliet S. Vitamin K, an update for the paediatrician. Eur J Pediatr 2009;168: 127-34.
DOI
ScienceOn
|
32 |
American Academy of Pediatrics, Committee on Nutrition. Pediatric nutrition handbook. 6th ed. Elk Grove Village: American Academy of Pediatrics, 2009:468-71.
|
33 |
Shapiro AD, Jacobson LJ, Armon ME, Manco-Johnson MJ, Hulac P, Lane PA, et al. Vitamin K deficiency in the newborn infant: prevalence and perinatal risk factors. J Pediatr 1986;109:675-80.
DOI
|
34 |
von Kries R, Hanawa Y. Neonatal vitamin K prophylaxis. Report of Scientific and Standardization, Subcommittee on Perinatal Haemostasis. Thromb Haemost 1993;69:293-5.
|
35 |
Schubiger G, Stocker C, Bänziger O, Laubscher B, Zimmermann H. Oral vitamin K1 prophylaxis for newborns with a new mixedmicellar preparation of phylloquinone: 3 years experience in Switzerland. Eur J Pediatr 1999;158:599-602.
DOI
ScienceOn
|
36 |
Clark FI, James EJ. Twenty-seven years of experience with oral vitamin K1 therapy in neonates. J Pediatr 1995;127:301-4.
DOI
ScienceOn
|
37 |
Vietti TJ, Murphy T, James JA, Pritchard JA. Observation on the prophylactic use of vitamin K in the newborn. J Pediatr 1960;56: 343-6.
DOI
|
38 |
Cornelissen EA, Kollee LA, De Abreu RA, Motohara K, Monnens LA. Prevention of vitamin K deficiency in infancy by weekly administration of vitamin K. Acta Paediatr 1993;82:656-99.
|
39 |
Lippi G, Franchini M. Vitamin K in neonates: facts and myths. Blood Transfus 2011;9:4-9.
|
40 |
Bick RL. Disseminated intravascular coagulation: a review of etiology, pathophysiology, diagnosis, and management: guidelines for care. Clin Appl Thromb Hemost 2002;8:1-31.
DOI
ScienceOn
|
41 |
Veldman A, Fischer D, Nold MF, Wong FY. Disseminated intravascular coagulation in term and preterm neonates. Semin Thromb Hemost 2010;36:419-28.
DOI
ScienceOn
|
42 |
Levi M, Ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999;341:586-92.
DOI
ScienceOn
|
43 |
Kreuz W, Veldmann A, Fischer D, Schlosser R, Volk WR, Ettingshausen CE. Neonatal sepsis: a challenge in hemostaseology. Semin Thromb Hemost 1999;25:531-5.
DOI
|
44 |
von Kries R, Stannigel H, Göbel U. Anticoagulant therapy by continuous heparin-antithrombin III infusion in newborns with disseminated intravascular coagulation. Eur J Pediatr 1985;144:191-4.
DOI
ScienceOn
|
45 |
Schmidt B, Gillie P, Mitchell L, Andrew M, Caco C, Roberts R. A placebo-controlled randomized trial of antithrombin therapy in neonatal respiratory distress syndrome. Am J Respir Crit Care Med 1998;158:470-6.
DOI
ScienceOn
|
46 |
Fourrier F, Chopin C, Huart JJ, Runge I, Caron C, Goudemand J. Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation. Chest 1993;104:882-8.
DOI
ScienceOn
|
47 |
Risch L, Huber AR, Schmugge M. Diagnosis and treatment of heparin-induced thrombocytopenia in neonates and children. Thromb Res 2006;118:123-35.
DOI
ScienceOn
|
48 |
Newall F, Johnston L, Ignjatovic V, Monagle P. Unfractionated heparin therapy in infants and children. Pediatrics 2009;123:e510-8.
DOI
ScienceOn
|
49 |
Martchenke J, Boshkov L. Heparin-induced thrombocytopenia in neonates. Neonatal Netw 2005;24:33-7.
|